Thomas Paccalet

Thomas Paccalet

Auto-generated profile, based on publicly available information

Thomas Paccalet

Direction générale adjointe -Planification stratégique et performance Bureau de l'innovation et du numérique propulsé par la recherche (BIN R ) Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale Quebec City QC Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Biological Psychiatry
Verified
Journal Article
Closed access
MHMarc Hébert
Marc Hébert
CMChantal Mérette
Chantal Mérette
AGAnne-Marie Gagné
Anne-Marie Gagné
TPThomas Paccalet
Thomas Paccalet
IMIsabel Moreau
Isabel Moreau
MMMichel Maziade
Michel Maziade

10 November 2003 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
MBMuriel Bardor
Muriel Bardor
CLCorinne Loutelier‐Bourhis
Corinne Loutelier‐Bourhis
TPThomas Paccalet
Thomas Paccalet
PCPascal Cosette
Pascal Cosette
AFAnne‐Catherine Fitchette
Anne‐Catherine Fitchette
PLPatrice Lerouge
Patrice Lerouge
Summary: Structural analysis of the N‐glycosylation of alfalfa proteins was investigated in order to evaluate the capacity of this plant to perform this biologically important post‐translational modification. We show that, in alfalfa, N‐linked glycans are processed into a large variety of mature oligosaccharides having core‐xylose and core α(1,3)‐fucose, as well as terminal Lewisa epitopes. In contrast, expression of the C5‐1 monoclonal antibody in alfalfa plants results in the production of plant‐derived IgG1 which is N‐glycosylated by a predominant glycan having a α(1,3)‐fucose and a β(1,2)‐xylose attached to a GlcNAc2Man3GlcNAc2 core. Since this core is common to plant and mammal N‐linked glycans, it therefore appears that alfalfa plants have the ability to produce recombinant IgG1 having a N‐glycosylation that is suitable for in vitro or in vivo glycan remodelling into a human‐compatible plantibody. For instance, as proof of concept, in vitro galactosylation of the alfalfa‐derived C5‐1 mAb resulted in a homogenous plantibody harbouring terminal β(1,4)‐galactose residues as observed in the mammalian IgG.

1 November 2004 in Nature Biotechnology
Verified
Journal Article
Closed access
MSMartial Séveno
Martial Séveno
MBMuriel Bardor
Muriel Bardor
TPThomas Paccalet
Thomas Paccalet
VGVéronique Gomord
Véronique Gomord
PLPatrice Lerouge
Patrice Lerouge
LFLoïc Faye
Loïc Faye

1 March 2015 in Schizophrenia Research
Verified
Journal Article
Closed access
MHMarc Hébert
Marc Hébert
CMChantal Mérette
Chantal Mérette
TPThomas Paccalet
Thomas Paccalet
CÉClaudia Émond
Claudia Émond
AGAnne-Marie Gagné
Anne-Marie Gagné
MMMichel Maziade
Michel Maziade

21 April 2010 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
MMMichel Maziade
Michel Maziade
NRNancie Rouleau
Nancie Rouleau
CMChantal Mérette
Chantal Mérette
CCCaroline Cellard
Caroline Cellard
MBMarco Battaglia
Marco Battaglia
MRMarc-André Roy
Marc-André Roy
Objective: Memory deficits have been shown in patients affected by schizophrenia (SZ) and bipolar (BP)/mood disorder. We recently reported that young high-risk offspring of an affected parent were impaired in both verbal episodic memory (VEM) and visual episodic memory (VisEM). Understanding better the trajectory of memory impairments from childhood to adult clinical status in risk populations is crucial for early detection and prevention. In multigenerational families densely affected by SZ or BP, our aim was to compare the memory impairments observed in young nonaffected offspring with memory functioning in nonaffected adult relatives and patients. Methods: For 20 years, we followed up numerous kindreds in the Eastern Québec population. After having characterized the Diagnostic and Statistical Manual of Mental Disorders phenotypes, we assessed cognition (N = 381) in 3 subsamples in these kindreds and in controls: 60 young offspring of a parent affected by SZ or BP, and in the adult generations, 92 nonaffected adult relatives and 40 patients affected by SZ or BP. VEM was assessed with the California Verbal Learning Test and VisEM with the Rey figures. Results: The VEM deficits observed in the offspring were also found in adult relatives and patients. In contrast, the VisEM impairments observed in the young offspring were present only in patients, not in the adult relatives. Conclusion: Implications for prevention and genetic mechanisms can be drawn from the observation that VEM and VisEM would show distinct generational trajectories and that the trajectory associated with VisEM may offer a better potential than VEM to predict future risk of developing the disease.

31 October 2013 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
EGElsa Gilbert
Elsa Gilbert
CMChantal Mérette
Chantal Mérette
VJValérie Jomphe
Valérie Jomphe
CÉClaudia Émond
Claudia Émond
NRNancie Rouleau
Nancie Rouleau
MMMichel Maziade
Michel Maziade